23
Views
1
CrossRef citations to date
0
Altmetric
Review

Tumors of the optic nerve

&
Pages 197-206 | Published online: 09 Jan 2014

References

  • Arkhangelsky VN. Neoplasms of the optic nerve. Ophthalmologica151(2), 260–271 (1966).
  • Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lecture, part 1. Ophthalmology111(5), 997–1008 (2004).
  • Johansen S, Heegaard S, Bogeskov L, Prause JU. Orbital space-occupying lesions in Denmark 1974–1997. Acta Ophthalmol. Scand.78(5), 547–552 (2000).
  • Hollander MD, FitzPatrick M, O’Connor SG, Flanders AE, Tartaglino LM. Optic gliomas. Radiol. Clin. North Am.37(1), 59–71, ix (1999).
  • Lindegaard J, Heegaard S, Prause JU. Histopathologically verified non-vascular optic nerve lesions in Denmark 1940–99. Acta Ophthalmol. Scand.80(1), 32–37 (2002).
  • Wong JY, Uhl V, Wara WM, Sheline GE. Optic gliomas. A reanalysis of the University of California, San Francisco experience. Cancer60(8), 1847–1855 (1987).
  • Chavez M, Mafee MF, Castillo B et al. Medulloepithelioma of the optic nerve. J. Pediatr. Ophthalmol. Strabismus41(1), 48–52 (2004).
  • Biswas J, Bhushan B, Jayakumar N, Chidambaram B. Teratoid malignant medulloepithelioma of the optic nerve: report of a case and review of the literature. Orbit18(3), 191–196 (1999).
  • Takei H, Florez L, Moroz K, Bhattacharjee MB. Medulloepithelioma: two unusual locations. Pathol. Int.57(2), 91–95 (2007).
  • Green WR, Iliff WJ, Trotter RR. Malignant teratoid medulloepithelioma of the optic nerve. Arch. Ophthal.91(6), 451–454 (1974).
  • Chidambaram B, Santosh V, Balasubramaniam V. Medulloepithelioma of the optic nerve with intradural extension – report of two cases and a review of the literature. Childs Nerv. Syst.16(6), 329–333 (2000).
  • Reese AB. Medulio-epithelioma (dictyoma) of the optic nerve. Am. J. Ophthalmol.44(1), 4–6 (1957).
  • Andersen SR. Differentiation features in some retinal tumors and in dysplastic retinal conditions. Am. J. Ophthalmol.1(1 Part 2), 231–241 (1971).
  • Albayrak R, Albayram S, Port J et al. Ganglioglioma of the right optic tract: case report and review of the literature. Magn. Reson. Imaging22(7), 1047–1051 (2004).
  • Gritzman MC, Snyckers FD, Proctor NS. Ganglioglioma of the optic nerve. A case report. S. Afr. Med. J.63(22), 863–865 (1983).
  • Cogan DG, Poppen JL, Hicks SP. Ganglioneuroma of chiasm and optic nerves. Arch. Ophthal.65, 481–482 (1961).
  • Lowes M, Bojsen-Moller M, Vorre P, Hedegaard O. An evaluation of gliomas of the anterior visual pathways. A 10-year survey. Acta Neurochirurgica43(3–4), 201–206 (1978).
  • Lu WY, Goldman M, Young B, Davis DG. Optic nerve ganglioglioma. Case report. J. Neurosurg.78(6), 979–982 (1993).
  • Bergin DJ, Johnson TE, Spencer WH, McCord CD. Ganglioglioma of the optic nerve. Am. J. Ophthalmol.105(2), 146–149 (1988).
  • Sadun F, Hinton DR, Sadun AA. Rapid growth of an optic nerve ganglioglioma in a patient with neurofibromatosis 1. Ophthalmology103(5), 794–799 (1996).
  • Schwent BJ, Wojno TH, Grossniklaus HE. Hemangiopericytoma of the optic nerve sheath. Am. J. Ophthalmol.143(5), 904–906 (2007).
  • In S, Miyagi J, Kojho N, Kuramoto S, Uehara M. Intraorbital optic nerve hemangioblastoma with von Hippel–Lindau disease. Case report. J. Neurosurg.56(3), 426–429 (1982).
  • Higashida T, Sakata K, Kanno H et al. Hemangioblastoma of the optic nerve – case report. Neurol. Med. Chir. (Tokyo)47(5), 215–218 (2007).
  • Kerr DJ, Scheithauer BW, Miller GM, Ebersold MJ, McPhee TJ. Hemangioblastoma of the optic nerve: case report. Neurosurgery36(3), 573–580; discussion 580–571 (1995).
  • Rubio A, Meyers SP, Powers JM, Nelson CN, de Papp EW. Hemangioblastoma of the optic nerve. Hum. Pathol.25(11), 1249–1251 (1994).
  • Nerad JA, Kersten RC, Anderson RL. Hemangioblastoma of the optic nerve. Report of a case and review of literature. Ophthalmology95(3), 398–402 (1988).
  • Eckstein RP, Wills EJ, Segelov JN. Haemangioblastoma of the optic nerve. Case report with study by light and electron microscopy. Pathology13(2), 357–364 (1981).
  • Lauten GJ, Eatherly JB, Ramirez A. Hemangioblastoma of the optic nerve: radiographic and pathologic features. AJNR2(1), 96–99 (1981).
  • Boniuk M, Messmer EP, Font RL. Hemangiopericytoma of the meninges of the optic nerve. A clinicopathologic report including electron microscopic observations. Ophthalmology92(12), 1780–1787 (1985).
  • Christmas NJ, Mead MD, Richardson EP, Albert DM. Secondary optic nerve tumors. Surv. Ophthalmol.36(3), 196–206 (1991).
  • Jensen OA. Malignant melanomas of the uvea in Denmark 1943–1952. A clinical, histopathological, and prognostic Study. Acta Ophthalmologica (Copenh.)43(Suppl. 75), 71–220 (1963).
  • Newman NJ, Grossniklaus HE, Wojno TH. Breast carcinoma metastatic to the optic nerve. Arch. Ophthal.114(1), 102–103 (1996).
  • Mansour AM, Dinowitz K, Chaljub G, Guinto FC. Metastatic lesion of the optic nerve. J. Clin. Neuroophthalmol.13(2), 102–104 (1993).
  • Arnold AC, Hepler RS, Foos RY. Isolated metastasis to the optic nerve. Surv. Ophthalmol.26(2), 75–83 (1981).
  • Millar MJ, Tumuluri K, Murali R et al. Bilateral primary optic nerve lymphoma. Ophthal. Plast. Reconstr. Surg.24(1), 71–73 (2008).
  • Zelefsky JR, Revercomb CH, Lantos G, Warren FA. Isolated lymphoma of the anterior visual pathway diagnosed by optic nerve biopsy. J. Neuroophthalmol.28(1), 36–40 (2008).
  • Mavrikakis I, Heran MK, Rootman J. MR findings in a patient with isolated intrinsic optic nerve lymphoma. Ophthal. Plast. Reconstr. Surg.22(6), 482–484 (2006).
  • Agarwal MR, Wagner P, Bedros AA. Unilateral optic nerve edema as the initial sign of recurrence of acute lymphoblastic leukemia. J. Pediatr.148(5), 703 (2006).
  • Spencer A, Lee J, Prayson RA. Optic nerve choristoma. Ann. Diagn. Pathol.9(2), 93–95 (2005).
  • Patankar T, Prasad S, Krishnan A, Laxminarayan R. Isolated optic nerve pseudotumor. Australas. Radiol.44(1), 101–103 (2000).
  • Ing EB, Garrity JA, Cross SA, Ebersold MJ. Sarcoid masquerading as optic nerve sheath meningioma. Mayo Clin. Proc.72(1), 38–43 (1997).
  • Dutton JJ. Gliomas of the anterior visual pathway. Surv. Ophthalmol.38(5), 427–452 (1994).
  • Chutorian AM, Schwartz JF, Evans RA, Carter S. Optic gliomas in children. Neurology14, 83–95 (1964).
  • Danoff BF, Kramer S, Thompson N. The radiotherapeutic management of optic nerve gliomas in children. Int. J. Radiat. Oncol. Biol. Phys.6(1), 45–50 (1980).
  • Wulc AE, Bergin DJ, Barnes D et al. Orbital optic nerve glioma in adult life. Arch. Ophthal.107(7), 1013–1016 (1989).
  • Hoyama E, Cruz AA, Colli BO, Matos JR, Chahud F. Isolated low grade pilocytic astrocytoma of the optic nerve in the elderly: case report. Arq. Bras. Oftalmol.71(1), 97–100 (2008).
  • Alvord EC Jr, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients’ age, tumor site, and treatment. J. Neurosurg.68(1), 85–98 (1988).
  • Hoyt WF, Meshel LG, Lessell S, Schatz NJ, Suckling RD. Malignant optic glioma of adulthood. Brain96(1), 121–132 (1973).
  • Taphoorn MJ, de Vries-Knoppert WA, Ponssen H, Wolbers JG. Malignant optic glioma in adults. Case report. J. Neurosurg.70(2), 277–279 (1989).
  • Dutton JJ. Optic nerve sheath meningiomas. Surv. Ophthalmol.37(3), 167–183 (1992).
  • Amoli FA, Mehrabani PM, Tari AS. Aggressive orbital optic nerve meningioma with benign microscopic features: a case report. Orbit26(4), 271–274 (2007).
  • Spoor TC, Kennerdell JS, Martinez AJ, Zorub D. Malignant gliomas of the optic nerve pathways. Am. J. Ophthalmol.89(2), 284–292 (1980).
  • Chin L, Gray JW. Translating insights from the cancer genome into clinical practice. Nature452(7187), 553–563 (2008).
  • Savar A, Cestari DM. Neurofibromatosis type I: genetics and clinical manifestations. Semin. Ophthalmol.23(1), 45–51 (2008).
  • Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann. Neurol.41(2), 143–149 (1997).
  • Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J. Pediatr.114(5), 788–792 (1989).
  • Meyer P, Eberle MM, Probst A, Tolnay M. Gangliogliom des Nervus opticus bei Neurofibromatose Recklinghausen Typ 1: Fallbericht und Literaturüberblick. Klin. Monatsbl. Augenheilkd.217(1), 55–58 (2000).
  • Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell75(4), 826 (1993).
  • Rouleau GA, Merel P, Lutchman M et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature363(6429), 515–521 (1993).
  • Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first Century perspective. Lancet Neurol.6(4), 340–351 (2007).
  • Bosch MM, Wichmann WW, Boltshauser E, Landau K. Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch. Ophthal.124(3), 379–385 (2006).
  • Spencer WH. Primary neoplasms of the optic nerve and its sheaths: clinical features and current concepts of pathogenetic mechanisms. Trans. Am. Ophthalmol. Soc.70, 490–528 (1972).
  • Shehata BM, Stockwell CA, Castellano-Sanchez AA et al. Von Hippel–Lindau (VHL) disease: an update on the clinico–pathologic and genetic aspects. Adv. Anat. Pathol.15(3), 165–171 (2008).
  • Miller NR, Solomon S. Retinochoroidal (optociliary) shunt veins, blindness and optic atrophy: a non-specific sign of chronic optic nerve compression. Aust. NZ J. Ophthalmol.19(2), 105–109 (1991).
  • Muci-Mendoza R, Arevalo JF, Ramella M et al. Optociliary veins in optic nerve sheath meningioma. Indocyanine green videoangiography findings. Ophthalmology106(2), 311–318 (1999).
  • Imes RK, Hoyt WF. Magnetic resonance imaging signs of optic nerve gliomas in neurofibromatosis 1. Am. J. Ophthalmol.111(6), 729–734 (1991).
  • Brodsky MC. The “pseudo-CSF” signal of orbital optic glioma on magnetic resonance imaging: a signature of neurofibromatosis. Surv. Ophthalmol.38(2), 213–218 (1993).
  • DiPaolo DP, Zimmerman RA, Rorke LB et al. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology195(3), 721–724 (1995).
  • Ortiz O, Flores RA. Clinical and radiologic evaluation of optic pathway lesions. Semin. Ultrasound CT MR19(3), 225–239 (1998).
  • Miller NR. Primary tumors of the optic nerve and its sheath. Eye18(11), 1026–1037 (2004).
  • Ortiz O, Schochet SS, Kotzan JM, Kostick D. Radiologic–pathologic correlation: meningioma of the optic nerve sheath. AJNR17(5), 901–906 (1996).
  • Pant I, Suri V, Chaturvedi S, Dua R, Kanodia AK. Ganglioglioma of optic chiasma: case report and review of literature. Childs Nerv. Syst.22(7), 717–720 (2006).
  • Word Health Organization. Astrocytic tumors. In: WHO Classification of Tumors of the Central Nervous System. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (Eds). International Agency for Research on Cancer (IARC), Lyon, France, 13–52 (2007).
  • Jones DT, Ichimura K, Liu L et al. Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolution shows an increasing tendency toward chromosomal copy number change with age. J. Neuropathol. Exp. Neurol.65(11), 1049–1058 (2006).
  • Kluwe L, Hagel C, Tatagiba M et al. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J. Neuropathol. Exp. Neurol.60(9), 917–920 (2001).
  • Wabbels B, Demmler A, Seitz J et al. Unilateral adult malignant optic nerve glioma. Graefes Arch. Clin. Exp. Ophthalmol.242(9), 741–748 (2004).
  • Hartel PH, Rosen C, Larzo C, Nestor S. Malignant optic nerve glioma (glioblastoma multiforme): a case report and literature review. WV Med. J.102(4), 29–31 (2006).
  • Radley MG, di Sant’Agnese PA, Eskin TA, Wilbur DC. Epithelial differentiation in meningiomas. An immunohistochemical, histochemical, and ultrastructural study – with review of the literature. Am. J. Clin. Pathol.92(3), 266–272 (1989).
  • Eggers H, Jakobiec FA, Jones IS. Tumors of the optic nerve. Doc. Ophthalmol.41(1), 43–128 (1976).
  • Marquardt MD, Zimmerman LE. Histopathology of meningiomas and gliomas of the optic nerve. Hum. Pathol.13(3), 226–235 (1982).
  • Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet. Cell Genet.93(3–4), 207–220 (2001).
  • Wellenreuther R, Kraus JA, Lenartz D et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am. J. Pathol.146(4), 827–832 (1995).
  • Eberhart CG, Kepner JL, Goldthwaite PT et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study. Cancer94(2), 552–560 (2002).
  • World Health Organization. Meningeal tumors. In: WHO Classification of Tumors of the Central Nervous System. Louis DN, Ohgaki H, Wiestler OD, Cavanee WK (Eds). International Agency for Research on Cancer (IARC), Lyon, France, 163–186 (2007).
  • Lantos PL, Louis DN, Rosenblum M, Kleihues P. Tumors of the nervous system. In: Greenfield’s Neuropathology. Graham DI, Lantos PL (Eds). Arnold, London, UK, 663–677 (1997).
  • Liu GT, Galetta SL, Rorke LB et al. Gangliogliomas involving the optic chiasm. Neurology46(6), 1669–1673 (1996).
  • Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr. Blood Cancer46(5), 586–596 (2006).
  • Liu GT. Optic gliomas of the anterior visual pathway. Curr. Opin. Ophthalmol.17(5), 427–431 (2006).
  • Kennerdell JS, Maroon JC, Malton M, Warren FA. The management of optic nerve sheath meningiomas. Am. J. Ophthalmol.106(4), 450–457 (1988).
  • Turbin RE, Thompson CR, Kennerdell JS, Cockerham KP, Kupersmith MJ. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology109(5), 890–899; discussion 899–900 (2002).
  • Turbin RE, Pokorny K. Diagnosis and treatment of orbital optic nerve sheath meningioma. Cancer Control11(5), 334–341 (2004).
  • Jeremic B, Pitz S. Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice. Cancer110(4), 714–722 (2007).
  • Sarkies NJ. Optic nerve sheath meningioma: diagnostic features and therapeutic alternatives. Eye1(Pt 5), 597–602 (1987).
  • Gabibov GA, Blinkov SM, Tcherekayev VA. The management of optic nerve meningiomas and gliomas. J. Neurosurg.68(6), 889–893 (1988).
  • Miller NR. The evolving management of optic nerve sheath meningiomas. Br. J. Ophthalmol.86(11), 1198 (2002).
  • Miller NR. Radiation for optic nerve meningiomas: is this the answer? Ophthalmology109(5), 833–834 (2002).
  • Richards JC, Roden D, Harper CS. Management of sight-threatening optic nerve sheath meningioma with fractionated stereotactic radiotherapy. Clin. Experiment. Ophthalmol.33(2), 137–141 (2005).
  • Landert M, Baumert BG, Bosch MM, Lutolf UM, Landau K. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas. J. Neuroophthalmol.25(2), 86–91 (2005).
  • Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr. Neurol.28(4), 262–270 (2003).
  • Venes JL, Latack J, Kandt RS. Postoperative regression of opticochiasmatic astrocytoma: a case for expectant therapy. Neurosurgery15(3), 421–423 (1984).
  • Borit A, Richardson EP Jr. The biological and clinical behaviour of pilocytic astrocytomas of the optic pathways. Brain105(Pt 1), 161–187 (1982).
  • Parsa CF, Hoyt CS, Lesser RL et al. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch. Ophthal.119(4), 516–529 (2001).
  • Wilson WB, Feinsod M, Hoyt WF, Nielsen SL. Malignant evolution of childhood chiasmal pilocytic astrocytoma. Neurology26(4), 322–325 (1976).
  • Trigg ME, Swanson JD, Letellier MA. Metastasis of an optic glioma through a ventriculoperitoneal shunt. Cancer52(4), 599–601 (1983).
  • Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningiomas. Arch. Ophthal.120(11), 1505–1508 (2002).
  • Wright JE, Call NB, Liaricos S. Primary optic nerve meningioma. Br. J. Ophthalmol.64(8), 553–558 (1980).
  • Wolsey DH, Larson SA, Creel D, Hoffman R. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J. AAPOS10(4), 307–311 (2006).
  • Falsini B, Ziccardi L, Lazzareschi I et al. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J. Neurooncol.88(1), 87–96 (2008).
  • Moradi P, Robson AG, Rose GE, Holder GE. Electrophysiological monitoring in a patient with an optic nerve glioma. Doc. Ophthalmol.117(2), 171–174 (2008).
  • Peng F, Juhasz C, Bhambhani K et al. Assessment of progression and treatment response of optic pathway glioma with positron emission tomography using α-[11C]methyl-tryptophan. Mol. Imaging Biol.9(3), 106–109 (2007).
  • Wick W, Naumann U, Weller M. Transforming growth factor-b: a molecular target for the future therapy of glioblastoma. Curr. Pharm. Des.12(3), 341–349 (2006).
  • Hegedus B, Banerjee D, Yeh TH et al. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. Cancer Res.68(5), 1520–1528 (2008).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.